Compare YUMC & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YUMC | MEDP |
|---|---|---|
| Founded | 1987 | 1992 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7B | 16.1B |
| IPO Year | N/A | 2016 |
| Metric | YUMC | MEDP |
|---|---|---|
| Price | $49.41 | $583.58 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $479.64 |
| AVG Volume (30 Days) | ★ 1.1M | 208.8K |
| Earning Date | 02-04-2026 | 02-09-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | 6.57 | ★ 25.36 |
| EPS | 2.40 | ★ 14.32 |
| Revenue | ★ $11,569,000,000.00 | $2,358,373,000.00 |
| Revenue This Year | $5.49 | $21.43 |
| Revenue Next Year | $5.76 | $11.99 |
| P/E Ratio | ★ $21.09 | $41.42 |
| Revenue Growth | 3.29 | ★ 13.88 |
| 52 Week Low | $41.00 | $250.05 |
| 52 Week High | $53.99 | $628.92 |
| Indicator | YUMC | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 55.56 | 44.84 |
| Support Level | $48.53 | $579.03 |
| Resistance Level | $51.38 | $605.25 |
| Average True Range (ATR) | 1.03 | 18.58 |
| MACD | 0.17 | -3.29 |
| Stochastic Oscillator | 56.25 | 5.49 |
With more than 18,000 units and USD 12 billion in systemwide sales in 2025, Yum China is the largest restaurant operator in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC and Pizza Hut, but the company's portfolio also includes other brands such as Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza. Yum China is a trademark licensee of Yum Brands, paying 3% of KFC and Pizza Hut's systemwide sales to the company it separated from 2016.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.